NY State Senate Bill 2011-S279

Senate Bill S279

2011-2012 Legislative Session

Requires the packaging on prescribed drugs to include a label which lists the country of origin of the prescribed drug

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 04, 2012	referred to health
Jan 05, 2011	referred to health

co-Sponsors

View additional co-sponsors

2011-S279 (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add Art 33-B §3398, Pub Health L; amd §6811-a, Ed L
Versions Introduced in 2009-2010 Legislative Session:: S3213

2011-S279 (ACTIVE) - Summary

Requires the packaging on prescribed drugs to include a label which lists the country of origin of the prescribed drug.

2011-S279 (ACTIVE) - Sponsor Memo

                                BILL NUMBER:S279

TITLE OF BILL:
An act
to amend the public health law and the education law, in relation to
required labeling on prescription drugs

PURPOSE:
To require the packaging on prescribed drugs to include a label that
lists the country of origin of the prescribed drug to inform consumers.

SUMMARY OF PROVISIONS:
Section one amends the public health law by adding a new article 33-B
which requires the packaging of a prescribed drug to include a label
that lists the country of origin of the drug.

Section two amends subdivision 2 of section 6811-a of the education
law by adding paragraph (c) to include country of origin on the list
of required markings on the packaging of a prescription drug.

Section three provides the effective date.

JUSTIFICATION:
Pharmaceutical ingredients and finished drugs are produced worldwide
and imported into the United States. According to the U.S. Department
of Commerce, more than $42 billion in drugs and drug ingredients were

imported into the U.S. from foreign nations in 2006. India and China
are rapidly becoming some of the largest suppliers of pharmaceutical
ingredients and finished drugs in the U.S. In the past five years,
Chinese pharmaceutical imports have more than doubled.
According to the u.s. Department of Commerce, in 2006, China exported
approximately $675 million in pharmaceuticals to the United States
and India sold finished drugs and ingredients worth more than $800
million in the United States. With recent concerns over toxins found
in toys, toiletries and drugs produced in China and other countries,
New York consumers should be made aware of where their prescription
drugs are made. Consumers are informed of where their clothing, toys
and household goods are made through a country of origin label, but
currently have no way of knowing where their prescription drugs come
from. This bill would allow New Yorkers to be informed of where their
prescribed drugs are made just as they are informed of where other
goods are made.

LEGISLATIVE HISTORY:
S.6813 of 2007-2008; Referred to Senate Health Committee
S.3213 of 2009-2010; Referred to Senate Health Committee

FISCAL IMPLICATIONS:
None.

EFFECTIVE DATE:
This act shall take effect on the one hundred eightieth day after it
shall have become law.

2011-S279 (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                   279

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 5, 2011
                               ___________

Introduced  by  Sens.  MAZIARZ,  ALESI, BONACIC, GOLDEN, GRIFFO, LARKIN,
  NOZZOLIO, RANZENHOFER, SEWARD -- read twice and ordered  printed,  and
  when printed to be committed to the Committee on Health

AN ACT to amend the public health law and the education law, in relation
  to required labeling on prescription drugs

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The public health law is amended by adding  a  new  article
33-B to read as follows:
                              ARTICLE 33-B
                 REQUIRED LABELING ON PRESCRIPTION DRUGS
SECTION 3398. IDENTIFICATION OF THE COUNTRY OF ORIGIN OF A PRESCRIBED
                DRUG.
  S  3398. IDENTIFICATION OF THE COUNTRY OF ORIGIN OF A PRESCRIBED DRUG.
1.    NO  PRESCRIBED  DRUG  DISPENSED  BY  A  PHARMACY  PURSUANT  TO   A
PRESCRIPTION  BY  AN AUTHORIZED PRACTITIONER OF MEDICINE OR OTHER PERSON
LEGALLY AUTHORIZED TO ISSUE SUCH PRESCRIPTION MAY BE SOLD TO THE  PUBLIC
UNLESS  THE PACKAGING INCLUDES A LABEL WHICH LISTS THE COUNTRY OF ORIGIN
OF THE PRESCRIBED DRUG.
  2. WHENEVER THE ATTORNEY GENERAL SHALL BELIEVE FROM EVIDENCE SATISFAC-
TORY TO HIM OR HER THAT ANY PERSON, FIRM, CORPORATION OR ASSOCIATION  OR
AGENT OR EMPLOYEE THEREOF HAS VIOLATED ANY PROVISION OF THIS SECTION, HE
OR SHE MAY BRING AN ACTION IN THE SUPREME COURT OF THE STATE OF NEW YORK
FOR  A  JUDGMENT  ENJOINING  THE CONTINUANCE OF SUCH VIOLATION AND FOR A
CIVIL PENALTY OF NOT MORE THAN FIVE HUNDRED DOLLARS FOR EACH  VIOLATION.
IF  IT SHALL APPEAR TO THE SATISFACTION OF THE COURT OR JUSTICE THAT THE
DEFENDANT HAS VIOLATED ANY PROVISION OF THIS SECTION, NO PROOF SHALL  BE
REQUIRED THAT ANY PERSON HAS BEEN INJURED THEREBY NOR THAT THE DEFENDANT
KNOWINGLY  OR  INTENTIONALLY  VIOLATED  SUCH  PROVISION. IN SUCH ACTION,

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01665-01-1

S. 279                              2

PRELIMINARY RELIEF MAY BE GRANTED UNDER ARTICLE SIXTY-THREE OF THE CIVIL
PRACTICE LAW AND RULES.
  S 2. Subdivision 2 of section 6811-a of the education law, as added by
chapter 729 of the laws of 1981, is amended to read as follows:
  2. No drug for which any prescription is required by the provisions of
the Federal Food, Drug and Cosmetic Act or by the commissioner of health
contained  within  a  bottle, vial, carton or other container, or in any
way affixed or appended to or enclosed within a package of any kind, and
designed or intended for delivery in such container  or  package  to  an
ultimate  consumer,  shall  be  manufactured  or distributed within this
state unless such container  or  package  has  clearly  and  permanently
marked  or  imprinted  upon  it  in conformance with the applicable plan
required by subdivision three of this section:
  (a) an individual symbol, N.  D.  C.  number,  company  name,  number,
letters, words or marking identifying the manufacturer or distributor of
the drug;
  (b)  an  N.  D.  C.  number, symbol, number, letters, words or marking
identifying such drug or combination of drugs; [and]
  (c) ITS COUNTRY OF ORIGIN; AND
  (D) whenever the distributor of the prescription drug product does not
also manufacture the product the names and places of  business  of  both
shall appear on the label in words clearly distinguishing each.
  S 3. This act shall take effect on the one hundred eightieth day after
it shall have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.